Adaptin Bio (APTN) Other Working Capital Changes (2025 - 2026)
Adaptin Bio (APTN) reported Other Working Capital Changes of -$88282.0 for Q1 2026, down 118.85% year-over-year from $468321.0 in Q1 2025, and up 63.28% sequentially from -$240400.0 in Q4 2025.
Adaptin Bio (APTN) Other Working Capital Changes (2025 - 2026) Analysis & Trends
Adaptin Bio has disclosed Other Working Capital Changes across 2 years of filings, most recently posting -$88282.0 for Q1 2026.
- Quarterly Other Working Capital Changes fell 118.85% year-over-year to -$88282.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$408072.0 (changed N/A YoY) and the FY2025 annual result came in at $148531.0, up 1196.76% from the prior year.
- Other Working Capital Changes improved to -$88282.0 in Q1 2026, from -$240400.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $468321.0 in Q1 2025 and bottomed at -$240400.0 in Q4 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -88,282.00 |
| Mar 31, 2026 | -88,282.00 |
| Dec 31, 2025 | -240,400.00 |
| Dec 31, 2025 | -240,400.00 |
| Sep 30, 2025 | 89,270.00 |
| Sep 30, 2025 | 89,270.00 |
| Jun 30, 2025 | -168,660.00 |
| Jun 30, 2025 | -168,660.00 |
| Mar 31, 2025 | 468,321.00 |
| Mar 31, 2025 | 468,321.00 |